Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

The age of onset of diabetes and glutamic acid decarboxylase titer measured long after diagnosis are associated with the clinical stage of slow-onset type 1 diabetes.

Katahira M, Hanakita M, Ito T, Suzuki M, Segawa S.

Diabetes Res Clin Pract. 2013 Feb;99(2):93-7. doi: 10.1016/j.diabres.2012.11.017. Epub 2012 Dec 27.

PMID:
23273838
[PubMed - indexed for MEDLINE]
2.

[Study on the postive frequency and distribution of glutamic acid decarboxylase antibody in phenotypic type 2 diabetec patients].

Li X, Zhou ZG, Haung G, Peng J, Yan X, Yang L, Wang JP, Deng ZM.

Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Oct;26(10):800-3. Chinese.

PMID:
16536308
[PubMed - indexed for MEDLINE]
3.

High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus.

Imagawa A, Itoh N, Hanafusa T, Katsura H, Yamaguchi A, Takeda A, Iwahashi H, Nakajima H, Miyagawa J, Namba M, Kuwajima M, Matsuzawa Y.

Res Commun Mol Pathol Pharmacol. 1996 Apr;92(1):43-52.

PMID:
8733827
[PubMed - indexed for MEDLINE]
4.

Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.

Abiru N, Takino H, Yano M, Kawasaki E, Yamasaki H, Yamaguchi Y, Akazawa S, Nagataki S.

J Autoimmun. 1996 Oct;9(5):683-8.

PMID:
8933285
[PubMed - indexed for MEDLINE]
5.

Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.

Ishii M, Hasegawa G, Fukui M, Obayashi H, Ohta M, Ogata M, Yoshioka K, Kitagawa Y, Nakano K, Yoshikawa T, Nakamura N.

Immunol Lett. 2005 Jul 15;99(2):180-5. Epub 2005 Mar 17.

PMID:
16009268
[PubMed - indexed for MEDLINE]
6.

Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity.

Moriguchi M, Noso S, Kawabata Y, Yamauchi T, Harada T, Komaki K, Babaya N, Hiromine Y, Ito H, Yamagata S, Murata K, Higashimoto T, Park C, Yamamoto A, Ohno Y, Ikegami H.

Metabolism. 2011 Jun;60(6):761-6. doi: 10.1016/j.metabol.2010.07.025. Epub 2010 Sep 9.

PMID:
20825955
[PubMed - indexed for MEDLINE]
7.

Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies.

Rattarasarn C, Diosdado MA, Ortego J, Leelawattana R, Soonthornpun S, Setasuban W, Jaruratanasirikul S, Patarakijvanich N.

Diabetes Res Clin Pract. 2000 Aug;49(2-3):107-11.

PMID:
10963821
[PubMed - indexed for MEDLINE]
8.

Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.

Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P.

Metabolism. 2003 Jan;52(1):25-9.

PMID:
12524658
[PubMed - indexed for MEDLINE]
9.

[Relation between insulin resistance and glutamic acid decarboxylase antibody titers in latent autoimmune diabetes in adults].

Li X, Huang G, Yan X, Yang L, Zhou ZG.

Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jun;30(6):1247-9. Chinese.

PMID:
20584648
[PubMed - indexed for MEDLINE]
Free Article
10.

Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa.

Panz VR, Kalk WJ, Zouvanis M, Joffe BI.

Diabet Med. 2000 Jul;17(7):524-7.

PMID:
10972582
[PubMed - indexed for MEDLINE]
11.

Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes.

Juneja R, Hirsch IB, Naik RG, Brooks-Worrell BM, Greenbaum CJ, Palmer JP.

Metabolism. 2001 Sep;50(9):1008-13.

PMID:
11555830
[PubMed - indexed for MEDLINE]
12.

CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody.

Abe T, Yamaguchi Y, Takino H, Fujita N, Yamauchi-Degawa M, Ozaki M, Yamakawa K, Sera Y, Sakamaki H, Uotani S, Kawasaki E, Awata T, Yamasaki H, Eguchi K.

Diabet Med. 2001 Sep;18(9):726-31.

PMID:
11606170
[PubMed - indexed for MEDLINE]
14.

Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender.

Zimmet PZ, Elliott RB, Mackay IR, Tuomi T, Rowley MJ, Pilcher CC, Knowles WJ.

Diabet Med. 1994 Nov;11(9):866-71.

PMID:
7705024
[PubMed - indexed for MEDLINE]
15.

The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.

Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P, Falorni A, Buzzetti R; NIRAD Study Group.

Diabetes Care. 2008 Mar;31(3):534-8. Epub 2007 Dec 4.

PMID:
18056891
[PubMed - indexed for MEDLINE]
16.

Clinical evaluation of a radioimmunoprecipitation assay for IA-2 antibody and comparison of GAD antibody in type 1 diabetes mellitus.

Ohta M, Ohta K, Obayashi H, Nakamura N, Shigeta H, Nakano K, Hasegawa G, Fukui M, Kitagawa Y, Nishimura M, Itoh N.

Autoimmunity. 2000 Sep;32(2):79-88.

PMID:
11078153
[PubMed - indexed for MEDLINE]
17.

Glutamic acid decarboxylase antibodies in non-insulin-dependent diabetes patients with secondary sulfonylurea failure in Thailand.

Rattarasarn C, Aguilar Diosdado M, Soonthornpun S.

Diabetes Res Clin Pract. 1997 Sep;37(3):193-7.

PMID:
9306041
[PubMed - indexed for MEDLINE]
18.

Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies.

Martino GV, Tappaz ML, Braghi S, Dozio N, Canal N, Pozza G, Bottazzo GF, Grimaldi LM, Bosi E.

J Autoimmun. 1991 Dec;4(6):915-23.

PMID:
1812896
[PubMed - indexed for MEDLINE]
19.

Human fibroblasts ubiquitously express glutamic acid decarboxylase 65 (GAD 65): possible effects of connective tissue inflammation on GAD antibody titer.

Kono T, Nishimura F, Sugimoto H, Sikata K, Makino H, Murayama Y.

J Periodontol. 2001 May;72(5):598-604.

PMID:
11394394
[PubMed - indexed for MEDLINE]
20.

Distinct genetic and immunological features in patients with onset of IDDM before and after age 40.

Lohmann T, Sessler J, Verlohren HJ, Schröder S, Rötger J, Dãhn K, Morgenthaler N, Scherbaum WA.

Diabetes Care. 1997 Apr;20(4):524-9.

PMID:
9096974
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk